The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Dysfunctional HDL and atherosclerotic cardiovascular disease
Open accessAbstract
High-density lipoproteins (HDLs) protect against atherosclerosis by removing excess cholesterol from macrophages through the ATP-binding cassette transporter A1 (ABCA1) and ATP-binding cassette transporter G1 (ABCG1) pathways involved in reverse cholesterol transport. Factors that impair the availability of functional apolipoproteins or the activities of ABCA1 and ABCG1 could, therefore, strongly influence atherogenesis. HDL also inhibits lipid oxidation, restores endothelial function, exerts anti-inflammatory and antiapoptotic actions, and exerts anti-inflammatory actions in animal models. Such properties could contribute considerably to the capacity of HDL to inhibit atherosclerosis. Systemic and vascular inflammation has been proposed to convert HDL to a dysfunctional form that has impaired antiatherogenic effects. A loss of anti-inflammatory and antioxidative proteins, perhaps in combination with a gain of proinflammatory proteins, might be another important component in rendering HDL dysfunctional. The proinflammatory enzyme myeloperoxidase induces both oxidative modification and nitrosylation of specific residues on plasma and arterial apolipoprotein A-I to render HDL dysfunctional, which results in impaired ABCA1 macrophage transport, the activation of inflammatory pathways, and an increased risk of coronary artery disease. Understanding the features of dysfunctional HDL or apolipoprotein A-I in clinical practice might lead to new diagnostic and therapeutic approaches to atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies have indicated a complete loss of function and dysfunction gain concerning anti-inflammatory, vasodilatory, and antiapoptotic activities.”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“However, there are instances where HDL’s ability to deliver cholesterol esters via SCARB1 may be reduced, indicating only a partial loss of function.”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“It was noted that HDL could lose its anti-inflammatory properties and even develop proinflammatory characteristics.”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“However, when it comes to antioxidative activity and cholesterol efflux capacity, the deficiency observed in HDL’s normal function falls short of complete dysfunction [9].”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Subsequent research has shown that the extent of HDL’s normal function loss and dysfunction gain can vary depending on its different biological activities.”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Dysfunctional HDL (dys-HDL) are HDL cholesterol particles with high pro-atherogenic characteristics, characterized by the loss of typical antioxidant properties, becoming carriers of oxidized lipids themselves.”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
In the citing paper
“Moreover, modulations in HDL particle composition can transform it to dysfunctional and, through this modulation, increase the risk of CVD40.”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [40]
In the citing paper
“Decrease in HDL has been regarded as one important risk factor for cardiovascular diseases40.”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citationEffects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Self-citationWiller (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206797 · Cited by 2,022
Self-citationCholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
HDL cholesterol efflux capacity and incident cardiovascular events
Rohatgi, A., Khera, A., Berry, J. D., Givens, E. G., Ayers, C. R., Wedin, K. E., Neeland, I. J., Yuhanna, I. S., Rader, D. R., de Lemos, J. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409065 · Cited by 1,390
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Self-citation
Cited by
Sorted by citations
Items 601–700 of 821
Laws, P., & Warren, R. B. (2020) · Springer eBooks · doi:10.1007/978-3-030-54859-9_27 · Cited by 2
Richardson, K. A., Richardson, L. T., & Bowden, R. G. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2030037 · Cited by 2
Wang, T., You, Y., Ding, Y., Yang, Z., Jiang, S., Gao, F., Liu, S., Shao, L., & Shen, Z. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1441123 · Cited by 2
Laws, P., Young, H. S., & Warren, R. B. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4432-8_21 · Cited by 3
Predictors of acute coronary syndrome in patients with ischaemic heart disease
Kochergin, N. А., Kochergina, A. M., & Ганюков, В. И. (2020) · Angiology and vascular surgery · doi:10.33529/angi02020302 · Cited by 2
Yoshida, H. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed173 · Cited by 2
Costacou, T., Vaisar, T., Miller, R. G., Davidson, W. S., Heinecke, J. W., Orchard, T. J., & Bornfeldt, K. (2023) · medRxiv · doi:10.1101/2023.11.06.23298165 · Cited by 2
Self-citationChen, J., Liu, J., & Yu, B. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-1592-5_11 · Cited by 1
Ciaccio, M., Agnello, L., Sasso, B. L., Giglio, R. V., & Ciaccio, A. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-24958-7_14 · Cited by 1
Development of Dyslipidemia in Atherosclerosis and Modern Approaches to its Treatment
Blagov, A. V., Sobenin, I. A., Sukhorukov, V. N., Glanz, V. Y., Pleshko, E. M., & Orekhov, A. N. (2024) · The Heart Surgery Forum · doi:10.59958/hsf.7341 · Cited by 1
Potential of low apolipoprotein A-I as a surrogate marker of vulnerable carotid artery plaques
Tsuchigauchi, S., Matsushige, T., Hashimoto, Y., Masahiro, H., Takahashi, H., Kobayashi, S., Shishido, T., Hara, N., Kaneyoshi, K., Uchida, S., et al. (2025) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2025.108231 · Cited by 1
Malick, W. A., Rosenson, R. S., Naidu, I., & Mechanick, J. I. (2025) · Springer eBooks · doi:10.1007/978-3-031-82888-1_5 · Cited by 1
Self-citationYao, J. (2025) · International Journal of Clinical and Experimental Pathology · doi:10.62347/qjpq2923 · Cited by 1
Hosogai, M., Matsushige, T., Tsuchigauchi, S., Takahashi, H., Shinichiro, O. K. U., & Horie, N. (2025) · Neurologia medico-chirurgica · doi:10.2176/jns-nmc.2024-0258 · Cited by 1
Qiu, S., Zhu, J., Yuan, M., & Guo, Z. (2025) · Population Health Metrics · doi:10.1186/s12963-025-00396-8 · Cited by 1
Abrego-Guandique, D. M., Caroleo, M. C., Luciani, F., & Cione, E. (2025) · Applied Biosciences · doi:10.3390/applbiosci4030034 · Cited by 1
Arterial Stiffness in Heart‐Healthy Indigenous Tsimane Forager‐Horticulturalists
Cao, T., Linares, E. C., Gutierrez, R. Q., Rodríguez, D. E., Cuata, J. B., Miyamoto, M. I., Rueden, C. R. V., Cummings, D. K., Hooper, P. L., Trumble, B. C., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.042978 · Cited by 1
Nguyen, D. T., Hoang, C., Truong, T., Nguyen, D. H., Lam, H. G., Sharma, A., Le, T., & Huynh, P. K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327977 · Cited by 5
Lipid metabolism disorders in metabolic syndrome
Polyakova, E. A. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6539 · Cited by 2
Trifonova, K., Yonkova, P., & Dzhelebov, P. (2025) · Metabolites · doi:10.3390/metabo15100656 · Cited by 1
Jian, G., He, S., Jiang, K., Wang, Z., Wang, J., Lan, H., Xie, G., Sheng, G., Yan, F., Wang, W., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1680746 · Cited by 1
Scilletta, S., Welsh, P. I., Beazer, J., Pino, A. D., & Sattar, N. A. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120565 · Cited by 1
Cui, Z., Zhu, Z., Shao, J., Zhang, S., Wang, Y., Jiang, M. C., & Yuan, B. (2025) · European journal of medical research · doi:10.1186/s40001-025-03368-8 · Cited by 1
Taradeh, M., Hardy, L. M., Dahik, V. D., Lhomme, M., Wang, H., Reydellet, C., Materne, C., Pukar, K. C., Bun, E., Clemessy, M., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102281 · Cited by 2
Self-citationElevated monocyte-to-HDL cholesterol ratio predicts severity of obstructive sleep apnea syndrome
Ahmed, A. M., Nur, S. M., Li, L., Hassan, A. E., & Xiaochen, Y. (2026) · Medicine · doi:10.1097/md.0000000000045795 · Cited by 1
Fu, C., Chen, J., Liu, K., Dong, H., & Li, X. (2026) · Mediators of Inflammation · doi:10.1155/mi/1925004 · Cited by 1
Yu, C., Zhang, X., Wang, R., Zhang, C., Gao, Y., Yixin, W. A. N. G., Lv, L., Wang, Z., & Zhang, H. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157975 · Cited by 1
Komaravolu, R. K., Chatterjee, N., Kumar, S., Allen, J. L., Durant, C. P., Wu, R., Valentin-Guillama, G. A., McSkimming, C. C., Drago, F., Taylor, A. M., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1749366 · Cited by 1
Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes
Wahab, R. A., & Mahmood, W. A. W. (2026) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514261422310 · Cited by 2
Anita Sherly, A., Srikantiah, R. M., Rohatgi, A. K., Hegde, A., Harish, S., & Shirali, A. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01413-3 · Cited by 1
Zhou, D., Sun, L., Li, N., Liang, Y., Gan, G., Liao, D., & Chen, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1819233 · Cited by 1
Xiao, J., Tian, M., 丁正杰, Mu, H., She, H., Li, H., Wang, B., Chen, H., Jia, Y., Wang, Y., et al. (2026) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2026.108279 · Cited by 1
Tian, Y., Zhang, X., Gao, S., & Wang, H. F. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00309-0 · Cited by 1
Choi, R., Chun, G., Lee, S. G., & Cho, S. E. (2026) · Metabolites · doi:10.3390/metabo16080531 · Cited by 2
Pharmaka mit Wirkung auf den Lipidstoffwechsel
Offermanns, S. (2016) · Springer-Lehrbuch · doi:10.1007/978-3-662-46689-6_43 · Cited by 1
Genetic Disorders of Lipoprotein Metabolism: Diagnosis and Management
Cupido, A. J., Stoekenbroek, R. M., & Kastelein, J. J. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-44203-7_21 · Cited by 1
Cardiovascular Effects of Metformin
Kurmanbekova, B. T., & Noruizbaeva, A. M. (2022) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2022-02-12 · Cited by 1
Lau, S., & Middleton, D. A. (2020) · Angewandte Chemie · doi:10.1002/ange.202004130 · Cited by 1
Atherosclerosis is the outcome of adaptive complexity in the Arterial Endothelial Microenvironment
Roy, T., Ray, A. G., & Bandyopadhyay, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00081-5 · Cited by 1
Weight loss benefits on HDL cholesterol persist even after weight regaining
Genua, I., Miñambres, I., Puig, R., Sardà, H., Fernández–Ananín, S., Sánchez‐Quesada, J. L., & Pérez, A. (2024) · Surgical Endoscopy · doi:10.1007/s00464-024-10826-7 · Cited by 1
Inflammation and Cardiovascular Outcomes
Satish, P., & Agarwala, A. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_10 · Cited by 1
Divya, G., Jayaprakash, N. S., & Venkataraman, K. (2018) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2018.0018 · Cited by 1
Arungovind, G., Kamalanathan, A. S., Padmanabhan, V., Manoharan, A., Chandrashekara, S., & Venkataraman, K. (2019) · Journal of Proteins and Proteomics · doi:10.1007/s42485-019-00018-6 · Cited by 1
Negi, P., Heikkilä, T., Tallgrén, T., Malmi, P., Lund, J., Sinisalo, J. P., Metso, J., Jauhiainen, M., Pettersson, K. S. I., Lamminmäki, U., et al. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113772 · Cited by 1
Pharmaka mit Wirkung auf den Lipidstoffwechsel
Offermanns, S. (2020) · Springer eBooks · doi:10.1007/978-3-662-58304-3_43 · Cited by 1
THE ATP-BINDING CASSETTE TRANSPORTER A1 GENE POLYMORPHISMS AND TYPE 2 DIABETES MELLITUS
Al‐Awaida, W., Al‐Ameer, H. J., Sharab, A., Fatima, G., & Hadi, N. R. (2022) · Era s journal of medical research · doi:10.24041/ejmr2022.07 · Cited by 1
Fahmi, I., Kamal, M., & Dianingtyas, H. E. (2022) · Jurnal Mitra Kesehatan · doi:10.47522/jmk.v4i2.143
Dyslipidemia in Metabolic Syndrome
Toh, S.-A. E. S., & Lee, M. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_58 · Cited by 1
The Potential Importance of Paraoxonase-1 in Surgical Patients
Vekić, J., & Kotur‐Stevuljević, J. (2019) · Journal of Investigative Surgery · doi:10.1080/08941939.2019.1606964 · Cited by 1
Proteomics: a tool to investigate of composition and function of HDL in hyperlipidemia
da Silva, A. R. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2022.tde-26082022-123137 · Cited by 1
Kazenwadel, J., Berezhnoy, G., Cannet, C., Schäfer, H., Geisler, T., Rohlfing, A., Gawaz, M., Merle, U., & Trautwein, C. (2022) · medRxiv · doi:10.1101/2022.12.20.22283729 · Cited by 1
How does berberine regulate metabolism through target cells?Preprint
Sun, A., Yang, H., Li, T., Luo, J., Zhou, L., Chen, R., Lin, Y., & Han, L. (2023) · doi:10.22541/au.168138767.79461299/v1
Guzzi, P. H., Cortese, F., Pedace, E., & Veltri, P. (2023) · Preprints.org · doi:10.20944/preprints202308.0546.v1 · Cited by 1
Guzzi, P. H., Pedace, E., & Veltri, P. (2023) · Preprints.org · doi:10.20944/preprints202310.0289.v1 · Cited by 1
Nissilä, E., Syed, S., Uvarov, P., Lokki, A. I., Laivuori, M., Chernyaeva, L., Roininen, E., Vataja, E., Tuhkala, A., Keskitalo, S., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6828685/v1 · Cited by 1
Atherogenic dyslipidemia: A marker of cardiovascular risk in treated hypertension
Malick, W. A., Dhaybi, O. A., & Bhatt, D. L. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.07.008 · Cited by 1
HDL-associated phosphatidylserine blunts myeloid activation and protects from atherosclerosisPreprint
Bernal, A., Hamid, A., Grao-Roldán, C., Scarpa, A., Sánchez, I. B., Nicolás-Ávila, J. Á., Pena-Couso, L., Yaghmour, M. H., Benguría, A., Rosado, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.26.689708 · Cited by 1
Characterization of oxysterols produced in macrophages and mechanisms of regulation
Chen, Y. (2016) · theses.fr (ABES) · doi:10.70675/379acbf2z8e6cz41dbza8eaza1ac615d59cd · Cited by 1
Protective Effect of Nitric Oxide and Natural Antioxidants on Stability of Blood Vessel
高, 明. (2016) · Hans Journal of Food and Nutrition Science · doi:10.12677/hjfns.2016.51001
Lipoproteomics : Environmental and Genetic Factors Affecting High-Density Lipoprotein (HDL)
Ljunggren, S. (2016) · Linköping University medical dissertations · doi:10.3384/diss.diva-131643
Immune-Mediated Accelerated Atherosclerosis
Gruber, S., Tsiantoulas, D., & Binder, C. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803267-1.00004-1
Molecular Mechanisms of Hyperalphalipoproteinemia
Yamashita, S., Masuda, D., Ohama, T., & Koseki, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812513-7.00001-x
OBSOLETE: Lipid-mediated Mechanisms of Atherosclerosis
Fan, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99555-2
Theodorou (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180119kt
Ferreira, G. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2017.tde-29112017-085932
Role of Cholesterol in Heart Disease
Vučić, V., & Masnikosa, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.21339-5
Wang, S., & Liyue, W. (2019) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2019.104022
Atherosclerosis in Rheumatology: Old and New Insights
Oreská, S., & Tomčík, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88605
Association Between Plasma Lipids Profile and Lipids Oxidizability in Healthy Men
Jafari, A., Khan-Abadi, B. J., Nejadi, N., & Farhadihosseinabadi, B. (2019) · Journal of Applied Biotechnology Reports · doi:10.29252/jabr.06.02.07
Mintser, O. P., & Заліський, В. М. (2019) · Medical Informatics and Engineering · doi:10.11603/mie.1996-1960.2019.1.10106
High-Density Lipoprotein: From Biological Functions to Clinical Perspectives
Liu, D. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91136 · Cited by 1
Inflamação e síndrome metabólica
Lemaire, D. C., de Lima, R. C., & dos Santos, L. A. (2018) · doi:10.7476/9786588211113.0005
高比重リポ蛋白（HDL）の新たな機能評価法の実用化と心血管病リスクの層別化
隆嗣, 杜., & Ishida, T. (2017) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.25.2_150
Francisquini, J. D., da Costa, J. D. C., Stephani, R., & Perrone, Í. T. (2021) · Research Society and Development · doi:10.33448/rsd-v10i9.18430
Kaseda, R., Hosojima, M., Kuwahara, S., Kabasawa, H., Aoki, H., Higuchi, Y., Kon, V., Narita, I., & Saito, A. (2021) · Journal of the American Nutrition Association · doi:10.1080/07315724.2021.1950584 · Cited by 1
Determination of Small and Dense of Low-Density Lipoprotein and Coronary Heart Disease
李, 国. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.118514
The risk factors of old silent brain infarctions in carotid artery stenosis
Liu, X., Wang, C., Wang, W. “., & Wang, Y. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05638-9
The Relationship Between TC/HDL-c and Disease Activity in Axial Spondyloarthritis PatientsPreprint
Sun, S., Huang, Y., Huang, Q., Liu, M., Feng, F., Ji, Z., Huang, L., Deng, W., & LI, T. W. (2021) · Research Square · doi:10.21203/rs.3.rs-960249/v1
Innovative Lipid Biomarkers and Long-Term Outcomes
Anderson, J. L. C. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.192996734
Two-Time Scale Control of a High Speed Planar Parallel Manipulator With Structural Flexibility
Kang, B.-S., & Mills, J. K. (2002)
Amiloidosis e inflamación: rol de la apolipoproteína A-I
Gisonno, R. A. (2021) · doi:10.35537/10915/129713
Genetic Disorders of Lipoprotein Metabolism: Diagnosis and Management
Cupido, A. J., Stoekenbroek, R. M., & Kastelein, J. J. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-45457-9_23
Hernáez, Á., Valussi, J., Pérez‐Vega, K. A., Castañer, O., & Fitó, M. (2018) · Reference series in phytochemistry · doi:10.1007/978-3-319-54528-8_33-1
Sirtori, C. R., & Ruscica, M. (2018) · doi:10.1093/med/9780198784906.003.0039_update_002
Effect Of The ABCA1 Agonist CS-6253 On Amyloid β And Lipoproteins Metabolism In Cynomolgus Monkeys.Preprint
Noveir, S. D., Kerman, B. E., Xian, H., Meuret, C. J., Smadi, S., Martinez, A. E., Johansson, J., Zetterberg, H., Parks, B. A., Kuklenyik, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1353214/v1
Exposure to Second-Hand Smoke Predicts Breast Cancer Occurrence among Malaysian Women
Rashid, A. A. A., Zahali, Z., Gan, S. H., Krishna, B. V. M., Abdullah, S., Abdullah, S. Z. S., & Mohamed, H. J. J. (2022) · Sains Malaysiana · doi:10.17576/jsm-2022-5103-17
Zhang, W., Liu, J., Huang, X., Gao, H., & Zhang, Q. (2022) · Current Drug Delivery · doi:10.2174/1567201819666220414120901
Luo, T., Guo, Z., Liu, D., Guo, Z., Chen, P., Ou, C., & Chen, M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4057216
Lipid-Mediated Mechanisms in Atherosclerosis
Liu, Q., Martinez, J., Hodge, J., & Fan, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99555-3
Har HDL-kolesterol og triglyserider en rolle i hjerte- og karsykdom?
Christensen, J. J. (2015) · Norsk tidsskrift for ernæring · doi:10.18261/ntfe.13.4.7
Xu, C., Chen, S., Du, F., Zong, A., Xu, T., & You, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2311338/v1
Editorial: Endogenous and exogenous factors influencing the function and metabolism of lipoproteins
Cervellati, C., Sergi, D., Loria‐Kohen, V., & Trentini, A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1097963
Li, Z., & Zhang, R. (2023) · Research Square · doi:10.21203/rs.3.rs-2497701/v1
Li, S., Zhang, W., & Liu, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2645859/v1
Dinanti, F. K., Mulyani, S. P., & Chodidjah (2023) · Jurnal Kesehatan Andalas · doi:10.25077/jka.v11i3.2074
Metadata
- Authors
- Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- MedStar Washington Hospital Center (US)
- University of California, Los Angeles (US)
- UNSW Sydney (AU)
- Inserm (FR)
- University of Washington (US)
- Columbia University (US)
- University of Kentucky (US)
- Corresponding author
- Rosenson, Robert S.
- Venue
- Nature Reviews Cardiology
- Published
- 2015-09-01
- Volume
- 13
- Issue
- 1
- Pages
- 48-60
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- PMC
- PMC6245940
- OpenAlex
- W2175680864
- Cited by
- 822
- References
- 131
- Citations by year
- 2026: 89 · 2025: 89 · 2024: 66 · 2023: 79 · 2022: 86 · 2021: 79 · 2020: 79 · 2019: 62 · 2018: 69 · 2017: 61 · 2016: 56 · 2015: 5
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DP3DK108209, P30DK017047)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- HDL dysfunction, atherosclerosis, apolipoprotein A-I, reverse cholesterol transport, ABCA1, ABCG1, myeloperoxidase, nitrosylation, oxidative modification, inflammation, endothelial function, coronary artery disease, atherogenesis, anti-inflammatory activity
- MeSH terms
- Humans, Lipoproteins, HDL, Macrophages, Smoking, Apolipoprotein A-I, ATP-Binding Cassette Transporters, Diabetes Complications, Atherosclerosis, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
